Welcome to our dedicated page for Cartesian Growth Iii SEC filings (Ticker: CGCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cartesian Growth Corporation III (CGCT) files regular SEC disclosures that document its operations as a special purpose acquisition company and the progress of its announced business combination with Factorial Inc. The most important filings for SPAC investors include Form 8-K reports disclosing material events such as business combination announcements, Form 425 communications related to the proposed merger, proxy statements (DEF 14A) containing transaction details and shareholder voting information, and periodic reports (10-Q and 10-K) showing the company's financial position and trust account status.
Form 425 filings are particularly valuable for CGCT investors, as these documents contain communications related to the business combination with Factorial. These filings include investor presentations, press releases, and other materials that explain the transaction rationale, valuation methodology, and combined company business plan. Reading these documents helps investors understand management's strategic thinking and the financial projections underlying the merger agreement.
SPAC investors should pay close attention to proxy statements (Form DEF 14A), which provide comprehensive details about the business combination including transaction terms, financing arrangements, shareholder redemption rights, voting procedures, and risk factors. These filings disclose the percentage of shares that may be redeemed while still allowing the transaction to close, the amount of PIPE financing committed, and any amendments to the original merger agreement. Our platform's AI summaries highlight these critical details, saving you from reviewing hundreds of pages of legal documentation.
Form 10-Q quarterly reports for Cartesian Growth Corporation III show the trust account balance, operating expenses, and time remaining to complete a business combination. SPACs face deadlines to complete transactions or return funds to shareholders, making these periodic reports important for tracking the company's timeline and financial resources. Form 8-K filings announce material events such as extension votes, changes to transaction terms, or updates on regulatory approvals, providing real-time visibility into deal progress.
Cartesian Growth Corporation III and Factorial Inc. have signed a Business Combination Agreement dated December 17, 2025 to pursue a proposed business combination. The transaction will be put to a shareholder vote, and the parties plan to file a Form S-4 registration statement with the SEC that will include a proxy statement/prospectus for CGC shareholders and Factorial stockholders.
The communication highlights that the deal may include a private placement of common stock (a PIPE) and describes extensive forward-looking statements about Factorial’s early-stage solid-state battery business and the combined company. It stresses numerous risks, including deal completion, regulatory approvals, financing, technology development, competition, and broader economic and policy conditions. Investors are urged to read the future S-4, proxy statement/prospectus and related SEC filings carefully once available, and the text clarifies that this is not an offer to sell or a solicitation to buy securities.
Cartesian Growth Corporation III agreed to merge with Factorial Inc., a solid-state battery company, under a Business Combination Agreement that will take Factorial public through a SPAC transaction. The deal implies a fully diluted equity value of
Before closing, Cartesian will domesticate from the Cayman Islands to Delaware and be renamed Factorial Holdings, Inc., issuing Series A and Series B common stock. All Factorial shares, options and RSUs will convert into equity or awards linked to the new public company based on a defined exchange ratio.
The transaction is supported by a committed PIPE financing of
Cartesian Growth Corporation III agreed to merge with solid-state battery developer Factorial Inc. in a SPAC business combination valuing Factorial at an implied fully diluted equity value of $1.1 billion. Before closing, CGC will domesticate from the Cayman Islands to Delaware and be renamed Factorial Holdings, Inc., with all existing CGC equity converting into new Series A common stock.
After the merger, Factorial will become a wholly owned subsidiary and its shareholders and founders will receive New Factorial common shares based on an exchange ratio tied to the $1.1 billion valuation. All Factorial options and RSUs will roll into new awards under a New Factorial equity plan.
The transaction is supported by a committed $100 million PIPE split between a sponsor affiliate and an institutional investor, and is targeted to close in mid-2026, subject to shareholder approvals, regulatory clearances, listing of the new shares on Nasdaq and other customary conditions. New long-term incentive and employee stock purchase plans, registration rights, warrant exchanges and staggered board and lock-up structures are also outlined.
Cartesian Growth Corporation III (CGCT) filed its Q3 2025 10-Q, reflecting SPAC-stage activity with interest income driving results. The company reported net income of $2,764,627 for the quarter, primarily from $2,901,973 of interest earned on investments in its Trust Account, offset by $137,346 in general and administrative costs.
Following its May 2025 IPO of 27,600,000 units at $10.00, the Trust Account held $280,669,717 as of September 30, 2025, invested in U.S. Treasury-focused mutual funds. Transaction costs totaled $18,821,468, including a $13,140,000 deferred underwriting fee. The company sold 6,800,000 private placement warrants for $6,800,000 and has 20,600,000 total warrants outstanding.
Cash was $660,638 outside the Trust, with operating cash use of $468,024 year-to-date. The company remains in its pre-combination phase and discloses substantial doubt about its ability to continue as a going concern absent a timely business combination within the stated completion window. As of November 14, 2025, shares outstanding were 27,600,000 Class A and 6,900,000 Class B.
FAQ
What is the current stock price of Cartesian Growth Iii (CGCT)?
What is the market cap of Cartesian Growth Iii (CGCT)?
